After the Chinese Sinopharm vaccine was launched in Singapore , the reaction was very enthusiastic. On September 10, a batch of 31,600 doses of Sinopharm vaccine arrived in Singapore and was sent to 46 private clinics across the island today.
(Photo source: Sinopharm Group )
These 46 clinics include:
- 8 Faith clinics (Appointment link: https://www.faithmedical.sg/sinopharm-covid-19-vaccine.html)
- Kangsheng Wellth Clinic (Appointment link: h ttps://thomsonwellthclinic.com/covid-19-sinopharm-vaccine/)
- 11 HeartlandHealth clinics (Appointment link: https://www.heartlandhealth.sg/covid-19-vaccform)
These clinics charge between 90 and 107 SGD.
It should be noted that due to the enthusiastic response, some clinics have stopped opening appointments.
Despite this, some clinics will still place other people interested in vaccination on the waiting list and then introduce more Sinopharm vaccines.
Singapore has now provided at least two hospitals and three clinics for Sinopharm vaccines. Together with these 46 clinics, more than 50 hospitals and clinics for Sinopharm vaccines are provided.
.1 million doses of Sinopharm vaccine
is expected to arrive before the end of October
According to Lianhe Zaobao, another batch of 100,000 doses of Sinopharm vaccine is expected to arrive before the end of October, and as many as 100 clinics will provide vaccination.
This batch of Sinopharm vaccine was introduced by Innova Medical Group.
Singapore study using
non-mRNA coronavirus vaccination additive
Government protests interdepartmental working group earlier announced that elderly people aged 60 and older and residents of nursing facilities can receive the third dose of Pfizer or Moderna vaccine six to nine months after completing vaccination.
People with moderate to severe immunodeficiency can receive the same third dose of mRNA vaccine as the first two doses two months after completing the two doses of vaccination.
The Ministry of Communications and News and Senior Minister of Health, Dr. Pujieli, in response to a question about vaccination today (September 14), revealed that the expert group of COVID-19 vaccines is actively studying the use of non-messenger ribonucleic acid (mRNA) vaccines for "mixed" treatment.
The Ministry of Health is also discussing with vaccine suppliers to provide non-mRNA vaccines as additives, and several of them are ready to submit applications to the Health Sciences Bureau.
Non-mRNA vaccines currently approved by World Health Organization include: Sinovac vaccines using inactivated technology, as well as Johnson & Johnson and AstraZeneca vaccines using adenovirus vectors.
